中华临床免疫和变态反应杂志2018，Vol.12Issue(2)：194-197,4.DOI:10.3969∕j.issn.1673-8705.2018.02.011
变应性鼻炎经淋巴结注射免疫治疗
Intralymphatic immunotherapy in allergic rhinitis
吴星儒 1刘婉舒 1欧祖镇 1陈超 1曾丹 1周维康2
作者信息
- 1. 646000 四川泸州,西南医科大学附属医院皮肤科
- 2. 400010,重庆市人民医院过敏反应科
- 折叠
摘要
Abstract
Allergic rhinitis ( AR) is one kind of chronic allergic diseases with an increasing incidence and over 600 million patients are affected worldwide. Allergen-specific immunotherapy ( SIT) is the only potential curable therapeutic method for allergic rhinitis, but only 4% of AR patients chosen SIT because of long course of treatment and adverse reactions, which decreased the compliance of patients. New approach to improve patient compliance and the efficacy of treatment is one of the focuses of research on SIT in AR. Intralymphatic immunotherapy ( ILIT) , a new route of administration was investigated in recent years. Progress on intralym-phatic immunotherapy of AR was reviewed in this article.关键词
变应性鼻炎/免疫疗法/淋巴结/综述Key words
Allergic rhinitis/Immunotherapy/Lymph node/Review引用本文复制引用
吴星儒,刘婉舒,欧祖镇,陈超,曾丹,周维康..变应性鼻炎经淋巴结注射免疫治疗[J].中华临床免疫和变态反应杂志,2018,12(2):194-197,4.
